chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Suspected vaccination failure; Shingles; I felt bad the day after each of them; Arm was pretty sore but didn't last long; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Shingles), feeling bad (Verbatim: I felt bad the day after each of them) and pain in arm (Verbatim: Arm was pretty sore but didn't last long). The outcome of the vaccination failure was unknown and the outcome of the shingles, feeling bad and pain in arm were not reported.   It was unknown if the reporter considered the vaccination failure, shingles, feeling bad and pain in arm to be related to Shingles vaccine and Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles, feeling bad and pain in arm to be related to Shingles vaccine and Shingles vaccine.   Additional Information: GSK Receipt Date: 23-JUN-2023 The case was received from the patient interactive digital media. The patient stated that he/she felt bad the day after each of them and it was worsen after 1st one .  The patient's arm was pretty sore but did not last long .  The patient stated that nothing to compare to the pain of shingles . This case was considered as suspected vaccination failure as details regarding time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
I have a lot of pain in arm, at night I started with inflammation and woke up with swelling on left chest.
11/03/21-11/04/21  MILD/DULL HEADACHE, INJECTION SITE SORENESS, NAUSEA, WEAK,  FEVER, CHILLS, FLUSHING, HOT
Patient was fine for almost 48 hours after the vaccination. Then she started having shortness of breath and lots of coughing. Patient has been trying to get this under control since then and is still dealing with this now. To me it sounds like a COPD exacerbation somehow brought on by the vaccination. She has been having to use Duoneb nebulizer solution every 6 hours around the clock and her rescue albuterol inhaler every 4 to 6 hours since this started.
Headache, Myalgia, Fever, CHILLS, SWEATING, HOT FLASHES Narrative:  ALSO NOTE EMPLOYEE HAD POSITIVE FOR COVID MARCH OF 2020
45min post 1st moderna covid vac developed rash across chest, throat tightness, pt self administered epi pen
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 03-MAR-2014, the patient was vaccinated with PROQUAD (Merck) (dose strength and route was not reported) (lot # J002302 and expiry date: 22-AUG-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting PROQUAD (Merck), nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for PROQUAD (Merck). This is one of the several reports from the same reporter. Additional information has been requested.
who received both doses of the Pfizer covid vaccine early on and they all got covid 19; who received both doses of the Pfizer covid vaccine early on and they all got covid 19; This is a spontaneous report from a contactable consumer. This consumer reported similar events for 5 patients. This is the 5th of 5 reports.   A 13-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), 1st dose via an unspecified route of administration on an unspecified date (at the age of 13-year-old) (Batch/Lot number was not reported) as a single dose, 2nd dose via an unspecified route of administration on an unspecified date (at the age of 13-year-old) (Batch/Lot number was not reported) as a single dose for COVID-19 immunisation.  The patient's medical history and concomitant medications were not reported.  The patient received both doses of the Pfizer COVID vaccine early on and the patient got COVID 19 on an unspecified date. The outcome of the event was unknown.   The lot number for BNT162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101133918 Same Reporter/Drug/AE, Different Patient
Around 3 PM on 4/22/05, she had diarrhea. After that time she had diarrhea 6 more times (from 3 PM to 10 PM).I called the ER and they said they couldn't do nothing for a baby with diarrhea, but for me to keep her hydrated with Pedialyte. So I did that.  On 4/23/05, she had diarrhea 8 times. On 4/24/05, she had diarrhea 6 times. She had diarrhea 4 times by 4/26/05. She did not have anymore diarrhea.
beginning 1 inch below inj site devel reddened areas on arm that turned dark & feel warm to touch lt arm 8NOV96 called doing well no f/u needed;
3/10/04 MMR + varicella 3/19/04 Febrile Seizure Had some croup symptoms. Had already had fever x 2 days before seizure occured.
This spontaneous report was received from a nurse regarding a 13 year female patient. Information on pertinent medical history, drug reactions/allergies and concomitant medications were not reported. On 11-SEP-2015, the patient received first dose of GARDASIL 9 intramuscularly and a second dose on 10-NOV-2016. No adverse effects were reported. No product quality complaint was involved. This is one of the two reports: 1611USA009361 (Same reporter link). Additional information is not expected as there is no consent to contact the reporter.
Patient reported allergies > sulpha- rash ; NSAIDs - anaphylaxis ; PCN - in childhood.  *30 minutes observation.* Pt reported a sore arm after first vaccine. About 1o min post 2nd vaccination developed itching of both arms and back.  Denied itching/swelling of airway, SOB, dizziness or other symptoms. Stated that this was how previous allergic reactions began.  HR 75, RR 20, BP 140/88 O2sat 98 at 11:20 am sitting in chair.  Given 50 mg of Benadryl PO.  States she has responded to Benadryl in the past and has not needed Epi.  Second set of vital signs at 11:24 P72, BP 146/88 sitting.  Itching diminished - no rash noted.  Face slightly flushed with warm, dry skin. Lung sounds clear.  Stated itching diminishing.  BP at 148/88 when stood up.  Denied dizziness or other problems other than slight itching of arms/back.  Walked to vehicle to be driven home by sister.  Will call 911 if symptoms increase on way home or call allergist for any further treatment.
Erratic night's sleep-achy limbs-headache.  Upon getting up in the morning I felt nauseous, exhausted & weak.  Had a dizzy spell and passed out.  Diastolic BP 44.  Tired & achy all day.
fatigue; Headache; Muscle aches; This spontaneous case was reported by a physician and describes the occurrence of FATIGUE (fatigue), HEADACHE (Headache) and MYALGIA (Muscle aches) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced FATIGUE (fatigue), HEADACHE (Headache) and MYALGIA (Muscle aches). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 13-Feb-2021, FATIGUE (fatigue), HEADACHE (Headache) and MYALGIA (Muscle aches) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant products also included birth control pills   This case was linked to MOD-2021-018247 (Patient Link).
Jan 8: chills, low grade fever Jan 9:  Itching skin and hives on extremities Jan 10:  Hives on back and stomach, sensation of thickening throat  Hives are bad in evening and at night; lesson during the day
Wife ran a fever for 2 days afterwards.; Initial information received on 23-Nov-2020 regarding an unsolicited non-valid non-serious social media ( case through  media received from a consumer/non-health care professional (HCP) (patient's husband) in the .  This case involves Adult female patient who's wife ran a fever for 2 days afterwards (pyrexia), while she received vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment(s), vaccination(s) and family history were not provided. Concomitant medication was not reported.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer, lot number not reported) via an unknown route at an unknown administration site as a prophylactic vaccination.  On an unspecified date, (latency unknown) after the administration of vaccine, the patient reported fever for 2 days afterwards. It was also reported that a lot of people have something after they get a flu shot.  No relevant laboratory tests were reported.  It was not reported if the patient received a corrective treatment.  At the time of reporting, outcome of the event was unknown.  There will be no information regarding the batch number of the case.
Redness and swelling around the site of Td injection. Area of swelling and redness 8 x 10cm. Pain in upper arm and up to the neck. Sx began soon after injection. Pt used ibuprofen for pain. Tx suggestions 5/15/03 ice to arm, ibuprofen.
w/in 24hr post vax a ring of papular erythema devel around the periphery of each inj site;rash blanched well;rash cleared spontaneously by 13AUG97;It did not respond to hydrocortisone cream;referred to MD;
Pt recvd Engerix-B on 21MAR91 & 22APR91; 1 wk p/1st dose  of vax, pt exp joint stiffness, aches & malaise for 1 wk; 1 wk p/2nd dose pt exp 3 wks of pharyngitis & fatigue; sore throat, fatigue & malaise persists;
This is a spontaneous report from a contactable consumer. This consumer reported similar events for 3 patients. This is first of two reports. A 16-year-old female patient of an unspecified ethnicity received TRUMENBA, Lot Number L13514, Expiration Date: 31Jul2016, intramuscular on 30Nov2015 at 0.5 ml single dose. The patient medical history and the patient's concomitant medications were not reported. The patient experienced hives of arm injected on 30Nov2015 with outcome of recovered. Therapeutic measures were taken as a result of event: BENADRYL. Follow-up (29JUL2016): Follow-up attempts are completed. No further information is expected.
I received the second dose of the vaccine on 1/4/21 and experienced fatigue, muscle aches, headache, and a fever of 99.6 beginning 36 hours after the vaccine was administered extending to about 60 hours after administration. I missed work on 1/6/21 due to symptoms.
C/o warmth, redness at injection site; weakness in hand/arm/fingers, approx. 5 mins. after vaccine. Ice applied to site. 11/4/99 a.m., reports sx's resolved.
Vaccines were administered at approximately 10:10 am. Sister received vaccines. When leaving, patient walked into the wall. His body was rigid and he had some jerking motions to his extremities, He slumped to the floor against the wall after hitting his face and head. His face, lips, gums, anad tongue were blue. Patient was not responding. Pulse 62. Positioned for a patient airway. O2 at 2 liters/min. At 10:25 am .2ml. of epinephrine was given, Patient opened his eyes, but wasn't talking. He was incontinent of stool and the estimated time of seizure activity was 30 seconds. 911 was called. At 10:26 am pulse 72, BP 68/41, Resp. 22. Was pale. Alert and talking. Remembers only that his head started to hurt. Lungs clear. Pulse oximeter 98%. Ambulance arrived. Taken to the emergency room. Mom reported patient was all right. Became light-headed and fell. No allergic reaction. CAT scan ok.
Prolonged vaccine-acquired rotavirus infection//Vaccine strain virus identified in 9 (8 SCID, 1 IPEX); This literature report as received from the authors of published article as stated below refers to 30 infants of unknown age and gender with immunocompromising conditions (IC). Historical conditions and concomitant medications were not reported.  On an unknown dates, the patients were vaccinated with a dose of rotavirus vaccine, live, oral, pentavalent(manufacturer unknown), orally for prophylaxis.  The authors characterize adverse events (AE) after rotavirus vaccine (RV) in infants with IC reported to the Vaccine Adverse Event Reporting System (VAERS). They search for RV reports received from February 2006 to December 2015 in infants with IC. On an unknown date, the patients experienced prolonged vaccine-acquired rotavirus infection. Diarrhea was the most common primary AE reported, others AEs included pneumonia, failure to thrive, rotavirus viremia, eczema, hemophagocytic syndrome, bronchiolitis. 27 Patients required hospitalization. Stool tested for rotavirus 19 (13 SCID, 6 non-SCID); 11 positive. Vaccine strain virus identified in 9 (8 SCID, 1 IPEX).  The outcome of rotavirus infection and vaccinia virus infection was unknown.    The reporter considered the events to be related to Rotavirus Vaccine, Live, Oral, Pentavalent(manufacturer unknown).  Upon internal review rotavirus infection and vaccinia virus infection were considered as medically significant events.     A copy of the published article is attached as further documentation of the patient's experience.
Within 1 minute of vaccine being given, client was slumped in the chair, unconscious and moaned very loudly x 2. Client then apneic, RN observed client to begin posturing with no tonic clonic movements observed; client was also incontinent. Client's pupils were dilated. Posturing continued for approximately 60-90 seconds until 0.15mg epinephrine was given at approximately 08:50 and oxygen applied 15 LPM, and then client regained consciousness within about 20 seconds and stopped posturing. Client was a little dazed and not oriented for about 5 minutes. A few minutes later, after sitting client up, client vomited. Client was then oriented x 3 and conversant. Paramedics then arrived and began client care. See vitals below. Client taken by EMS at 9:20 am. 8:52 am - BP 98/60 approximated two minutes after Epi, (no BP taken prior to Epi.) Pulse 60. RR apneic initially then approx 6/min. 8:54 am - BP 118/74. Pulse 100. O2 99%. RR 6/min. 8:57 am- BP 108/68. Pulse 87 and regular. Lugns CTA, unlabored, skin pale, warm dry. O2 99%. RR: 12/min. Assessment: Syncope followed by incontinence and posturing lasting approx 60-120 seconds, symptoms resolved within 10-20 seconds of epinephrine injection. Mother denies history of syncope with vaccines, nor seizure activity. Signs/sxs consistent with cardiovascular collapse and subsequent posturing.
Information has been received from a 48 year old female registered nurse who on 21-MAR-2007 at 19:28 was sprayed in the eye with ProQuad. It was reported that as the nurse was administering a dose of vaccine it sprayed that as the nurse was administering a dose of vaccine it sprayed from the needle into her eye. The nurse experienced eye irritation. The nurse irrigated her eye for one minute. She was not nursing or pregnant. She was advised to thoroughly irrigate the eye and then seek medical attention if there were any symptoms. Prescription drug treatment was not required. The patient was not hospitalized. Additional information has been requested.
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's pertinent medical history, concomitant therapies and drug reaction or allergies not reported. On an unknown date, the patient was vaccinated with an improperly stored dose of VARIVAX (exact dose and route of administration were not reported, lot # L002217, expiration date: 21-JAN-2017). The reporter could not specify temperature exposure or timeframe. No adverse effects were reported. Additional information is not expected as the reported did not wish to be contacted.
Confirmed Immunological Vaccine Failure; This spontaneous report received from a patient concerned a 20 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, and expiry: UNKNOWN) dose was not reported, 1 total administered on 10-APR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported.  On 20-MAY-2021, the patient experienced confirmed immunological vaccine failure. Laboratory data included: COVID-19 antibody test (NR: not provided) Negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of confirmed immunological vaccine failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint.; Sender's Comments: V0.20210546789-covid-19 vaccine ad26.cov2.s -confirmed immunological vaccine failure . This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Pt immediately presented AMS, Pale, loss of grip strength. Evaluated by EMS-Refusal to transport.
I had chills and felt unwell about 13 hrs. after the vaccine. In the days following, I noticed my lymph nodes on my left side were swollen. This persisted. I noticed my supraclavicular lymph node was also swollen. I went to the Doctor regarding this. My first 2 periods after the vaccine were heavier. I went to my OB GYN because I wasn't sure if it was due to the vaccine or my IUD. It was not due to the IUD. I was also feeling super tired. I also experienced a full feeling in my neck so I got my lymph's checked. I got labs done which all came back fine. I was still feeling tired and having lymphadenopathy so I went to my PCP.  Now, I still have the lymphadenopathy on my neck. It is not large enough to see. I also have a feeling of fullness in my neck. I also still have increased fatigue.
This spontaneous report as received from a nurse refers to unspecified number of patients of unknown age and gender. No information regarding concurrent conditions and medical history was reported. During the timeframe from 09-JUN2015 to 07-JUL-2015, the patients received GARDASIL (lot # K023432 and expiry date of 18-JUN-2016 and lot # K010574 and expiry date of 08-APR-2017) (unkonwn strength, route and dose), which was improperly exposed to 10.9 degree centigrade for 494 hours. Concomitant medications were not reported. No adverse effects were reported. The outcome of the event was unknown. There was no product quality complaint involved. This one of the several reports received from the same reporter. Additional information has been requested.
Patient presented with a prescription for cephalexin to treat possible infection from PREVNAR-13 vaccine. Patient has slightly sore, swollen, red, blotchy rash, no fever or pain.
Patient (myself) experienced lightheadedness, blurred/starry vision, clammy palms, intense cold sweat and almost fainted approximately 10-15 minutes after receiving Janssen COVID19 vaccine injection.  I was provided a small bag of cookies and a bottle of water while sitting in a chair.  These symptoms manifested a second time approximately 10 minutes after the first on-set and I was laid on the floor with feet elevated.
fatigue; muscle ache; red blotch on her right arm where she was vaccinated; burning sensation; diarrhea on and off.; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea on and off.), FATIGUE (fatigue), MYALGIA (muscle ache), VACCINATION SITE ERYTHEMA (red blotch on her right arm where she was vaccinated) and VACCINATION SITE PAIN (burning sensation) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, the patient experienced DIARRHOEA (diarrhea on and off.). On 28-Apr-2021, the patient experienced FATIGUE (fatigue), MYALGIA (muscle ache), VACCINATION SITE ERYTHEMA (red blotch on her right arm where she was vaccinated) and VACCINATION SITE PAIN (burning sensation). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency and CORTISONE for Adverse event, at a dose of Ointment. At the time of the report, DIARRHOEA (diarrhea on and off.), FATIGUE (fatigue), MYALGIA (muscle ache), VACCINATION SITE ERYTHEMA (red blotch on her right arm where she was vaccinated) and VACCINATION SITE PAIN (burning sensation) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported.
Narrative:  Presented to the ED cough that has been hurting his sides for 2 weeks. Cough was nonproductive and some sinus drainage. COVID positive - admitted to ICU/Observation unit.
There was only one day of a flu-like syndrome, which was mild. However, hoarseness of the voice continued. I am a serious and trained amateur singer, and my singing voice was badly affected for over a month. It didn't fully recover for about 4 months. The symptoms were similar to laryngeal reflux I have had in the past, but which has been well-controlled for several years. The treatment used was voice therapy exercises. The voice very gradually improved.
9:41am - Nurse called to parking lot for an emergency with this patient.  Upon approaching scene, patients husband and dental assistant -  were carrying patient inside to be assessed.  Patient appeared to be very limp and not fully awake.  9:42am - called 911.  Laid patient on cot and elevated legs.  Husband reports patient didn't completely pass out but came really close.  Patient able to state name and DOB.  Patient very pale and lethargic.  9:43am- BP 110/60, Pulse 60.  9:45am - Asked patient if she had ate anything.  Patient states no.  Sat her up and gave her small sips of Mtn. Dew.  Patient complaining of both hands numb and tingly.  States is starting to feel much better.  9:48am - ambulance arrived.  Patient evaluated by paramedics and continues to feel better.  Blood sugar, BP, Pulse, and o2 Sat all checked by EMT.  All WNL.  Patient continues to feel better.   Patient refuses to go by ambulance.   EMT wanted patient to stand up and walk to see how she felt.  Patient walked several feet and states that she feels much better and she is fine.  10:03am - walked patient to vehicle and patient left in stable condition with husband driving.
States tenderness to top of left rib below arm pit that started around 2/24/21 and went to PCP on 3/3/21 for evaluation. Reports bloodwork ordered. States she has been getting progressively worse with complaints of bilateral hip pain and discomfort to upper and lower back. Reports she had chills on 3/19/21 but no fever and has been in contact "daily" with PCP.
Has red blister like lesion on (R) arm & (R) thigh. Lesions are in different phases.